2 recruiting, 1 completed, 1 withdrawn. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Recruiting 2, Completed 1, Withdrawn 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Usual treatment: new trials by email Literature Review of Usual treatment trials Research Report on Usual treatment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis Intravenous immunoglobulin (IVIG), Usual treatment - Idiopathic Pulmonary Fibrosis, Acute Exacerbation of Idiopathic Pulmonary Fibrosis | Phase 3 | Recruiting | Argyrios Tzouvelekis | 196 | 2026-01-25 | 2026-03-16 |
| 5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer Combination cream of 5-fluorouracil and calcipotriene, 5-fluorouracil cream - Superficial Basal Cell Carcinoma, Squamous Cell Carcinoma in Situ | Phase 2 / Phase 3 | Recruiting | Boston University | 200 | 2022-10-15 | 2025-11-28 |
| PRP ULCERAS: Clinical Trial Phase III Platelet-Rich Plasma, Usual treatment - Ulcer | Phase 3 | Withdrawn | Basque Health Service | 2015-01-01 | 2020-02-25 | |
| Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Epilepsy AN-DBS, Usual treatment - Partial Epilepsy, Surgery | Phase 3 | Completed | University Hospital, Grenoble | 62 | 2014-06-16 | 2022-03-29 |
Epilepsies, Partial (1) · Idiopathic Pulmonary Fibrosis (1) · Squamous Intraepithelial Lesions (1) · Ulcer (1)
Argyrios Tzouvelekis (1) · Basque Health Service (1) · Boston University (1) · University Hospital, Grenoble (1)
France (1) · Greece (1) · Spain (1) · United States (1)
Bilal Fawaz, MD (1) · Gonzalo Grandes Odriozola (1) · Natalia Burgos Alonso. (1)
2014 (1)